KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 1 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $138,000 | -36.4% | 36,827 | -30.7% | 0.00% | -100.0% |
| Q1 2018 | $217,000 | +4.3% | 53,166 | +18.8% | 0.00% | 0.0% |
| Q4 2017 | $208,000 | -38.5% | 44,736 | -6.0% | 0.00% | 0.0% |
| Q3 2017 | $338,000 | +9.7% | 47,602 | +11.8% | 0.00% | 0.0% |
| Q2 2017 | $308,000 | +9.2% | 42,561 | -12.8% | 0.00% | -50.0% |
| Q1 2017 | $282,000 | +327.3% | 48,820 | +352.4% | 0.00% | +100.0% |
| Q4 2016 | $66,000 | -35.3% | 10,792 | -50.4% | 0.00% | – |
| Q1 2016 | $102,000 | -19.7% | 21,772 | -17.9% | 0.00% | – |
| Q4 2015 | $127,000 | +115.3% | 26,528 | +45.7% | 0.00% | – |
| Q3 2015 | $59,000 | -81.6% | 18,209 | -44.9% | 0.00% | -100.0% |
| Q2 2015 | $320,000 | -31.2% | 33,076 | -12.0% | 0.00% | 0.0% |
| Q1 2015 | $465,000 | -9.7% | 37,578 | +3.3% | 0.00% | -33.3% |
| Q4 2014 | $515,000 | +12.9% | 36,364 | +14.7% | 0.00% | 0.0% |
| Q3 2014 | $456,000 | +16.0% | 31,694 | +23.9% | 0.00% | +50.0% |
| Q2 2014 | $393,000 | -7.3% | 25,575 | +2.8% | 0.00% | -33.3% |
| Q1 2014 | $424,000 | +88.4% | 24,868 | +43.3% | 0.00% | +200.0% |
| Q4 2013 | $225,000 | +13.1% | 17,350 | -21.3% | 0.00% | 0.0% |
| Q3 2013 | $199,000 | +44.2% | 22,050 | +19.2% | 0.00% | 0.0% |
| Q2 2013 | $138,000 | – | 18,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HUNTINGTON NATIONAL BANK | 1 | $3 | 0.00% |